Showing 6201-6210 of 20929 results for "".
- EFFISAYIL 2: Spesolimab Associated with Long-Term GPP Reliefhttps://reachmd.com/news/effisayil-2-spesolimab-associated-with-long-term-gpp-relief/2474835/Patients with generalized pustular psoriasis (GPP) experienced sustained symptom control and quality of life (QoL) improvements when treated with spesolimab, according to an analysis of results from the EFFISAYIL 2 trial. Re
- Cardiac Hypertrophy: Adaptive Mechanism and Risks of Chronic Overloadhttps://reachmd.com/news/cardiac-hypertrophy-adaptive-mechanism-and-risks-of-chronic-overload/2474814/Cardiac hypertrophy is the heart’s primary adaptation to an increased workload, marked by thickening of the ventricular wall. However, sustained overload can transform this mechanism into a pathological process characterized by ventricular dilatation a
- Gut Microbiome: SCFA Signaling and Cardiovascular Healthhttps://reachmd.com/news/gut-microbiome-scfa-signaling-and-cardiovascular-health/2474811/Groundbreaking findings have demonstrated that gut-derived SCFAs interact with receptors to offer cardiovascular protection via mechanisms like vasodilation and modulation of the renin-angiotensin system. This discovery holds critical value for bot
- Navigating Legal and Clinical Frontiers in BMP-Driven Orthopedic Surgeryhttps://reachmd.com/news/navigating-legal-and-clinical-frontiers-in-bmp-driven-orthopedic-surgery/2474802/Bone Morphogenetic Proteins (BMPs) are increasingly explored in orthopedic surgery for their potential in bone repair, although legal and regulatory changes continue to influence their application. Bone Morphogenetic Proteins (BMPs), a
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://reachmd.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glutathio
- Prognostic Factors in Diffuse Glioma: The Limited Role of Tumor-Related Epilepsyhttps://reachmd.com/news/prognostic-factors-in-diffuse-glioma-the-limited-role-of-tumor-related-epilepsy/2474795/Advanced studies in oncology and neurology are reshaping the prognostic assessment methodology for diffuse glioma. While tumor-related epilepsy is a frequent occurrence, its presence alone is not a predictor of survival or disease progression. Clinicians are
- Genomic Risk Assessment: Predicting the Progression of Multiple Myelomahttps://reachmd.com/news/genomic-risk-assessment-predicting-the-progression-of-multiple-myeloma/2474794/Recent studies have led to the creation of a genomic score based on comprehensive DNA mutation analysis, anticipating the progression from benign precursor states to malignant multiple myeloma. This innovation not only reveals the genet
- Early Prediction of Bone Destruction in Rheumatoid Arthritis: Plasma Metabolites and Machine Learning Analysishttps://reachmd.com/news/early-prediction-of-bone-destruction-in-rheumatoid-arthritis-plasma-metabolites-and-machine-learning-analysis/2474769/Rheumatoid arthritis is a well-established inflammatory disease known for causing severe joint damage and bone degradation. Chronic inflammation incites a cascade leading to bone erosion, emphasizing the urgent need for early diagnostic
- Ulcerative Colitis: Evaluating Mediterranean Plant Extractshttps://reachmd.com/news/ulcerative-colitis-evaluating-mediterranean-plant-extracts/2474790/Recent experimental research confirms that strawberry tree extract can prevent and treat ulcerative colitis in animal models. These findings highlight the bioactive potential of Mediterranean plants, paving the way for innovative plant-based strategies in managing
- mHealth Apps and Cancer Screening: Community Engagement Approacheshttps://reachmd.com/news/mhealth-apps-and-cancer-screening-community-engagement-approaches/2474742/Current evaluations show that mHealth apps developed with community input dramatically enhance screening outcomes for both colorectal and breast cancers, whereas a notable gap remains in cervical cancer screening interventions. Recent advancemen